Related Experiment Video
Updated: Feb 8, 2026

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors
Published on: July 16, 2012
Human MxB Protein Is a Pan-herpesvirus Restriction Factor
Mirjam Schilling1, Lorenzo Bulli2, Sebastian Weigang1
1Institute of Virology, Medical Center-University of Freiburg, Freiburg, Germany.
The human MX2 gene product MxB restricts herpesvirus replication, acting as a broad antiviral factor. This dynamin-like GTPase differs in its mechanism against herpesviruses compared to HIV-1.
Area of Science:
- Virology
- Immunology
- Molecular Biology
Background:
- Herpesvirus infections are widespread and lifelong, posing risks to immunocompromised individuals.
- The interferon system is crucial for controlling herpesvirus replication, but effector mechanisms remain unclear.
- Human myxovirus resistance 2 (MX2) gene product MxB inhibits HIV-1.
Purpose of the Study:
- To investigate MxB's role in controlling herpesvirus replication.
- To elucidate the mechanism of MxB's antiviral activity against herpesviruses.
- To compare MxB's function against herpesviruses and HIV-1.
Main Methods:
- Investigated MxB's effect on alpha-, beta-, and gammaherpesviruses.
- Utilized defined MxB mutants to study GTP binding and hydrolysis.
- Analyzed MxB's impact on early viral gene expression.
Main Results:
- MxB inhibits herpesvirus replication at an early stage, before immediate early gene expression.
- MxB restricts all three subfamilies of herpesviruses.
- Mutational analysis revealed a distinct mechanism of action against herpesviruses compared to HIV-1.
Conclusions:
- MxB acts as a broad-spectrum intracellular restriction factor against both retroviruses and herpesviruses.
- MxB's antiviral mechanism against herpesviruses is distinct from its mechanism against HIV-1.
- MxB represents a significant host defense mechanism against herpesvirus infections.
More Related Videos
Related Concept Videos
Factors Affecting Protein-Drug Binding: Protein-Related Factors
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
Factors Affecting Protein-Drug Binding: Drug-Related Factors
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
Factors Affecting Protein-Drug Binding: Patient-Related Factors
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Transcription Factors
Restriction Enzymes
The host bacteria protect their own genomic DNA from these enzymes by methylating these sites. Some...
Factors Affecting Protein-Drug Binding: Drug Interactions
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...

